A New Era for Snakebite Treatment: Antivenom Innovation to Save Lives The high mortality rate from snakebites in India, where up to 50,000 people die annually from cobra bites alone, underscores the need for innovative solutions.
Current methods of antivenom production rely on outdated techniques such as venom milking and animal immunisation, which are costly, inefficient, and often yield limited results.
Researchers from India and Denmark have made a significant contribution by harnessing microbial systems to mass produce antibodies.